Novo Nordisk A/S News Headlines

NVO 
$47.75
*  
0.22
0.46%
Get NVO Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Arena: Belviq Sales Show Modest Gain - Time To Assess 2015 Expectations?
2/23/2015 10:33:00 AM - Seeking Alpha


Capturing The Growth Of The Diabetic Epidemic Via Shares Of Novo Nordisk
2/23/2015 9:10:00 AM - Seeking Alpha


Novo-Nordisk's Oral GLP-1 Diabetes Treatment: An Update
2/19/2015 11:25:00 AM - Seeking Alpha


Week In Review: Cellular Biomedicine In-Licenses Cancer Immunotherapy From China
2/15/2015 11:14:00 AM - Seeking Alpha


Dividend Contenders: 35 Increases Expected By The End Of April
2/15/2015 7:01:00 AM - Seeking Alpha


What MannKind Investors Can Learn From The Sanofi Conference Call
2/5/2015 2:37:00 PM - Seeking Alpha


With Flat Qsymia Sales, Vivus May Shift Focus To Stendra/Spedra
2/3/2015 2:44:00 PM - Seeking Alpha


Tracking Ken Fisher's Fisher Asset Management Portfolio - Q4 2014 Update
1/31/2015 10:54:00 AM - Seeking Alpha


European Markets To Follow Wall Street Higher
1/30/2015 2:24:00 AM - RTT News


Novo Nordisk 2014 Profit Rises - Quick Facts
1/30/2015 1:45:00 AM - RTT News


Gallup Says Obesity Rates Climb Again - Can Anti-Obesity Companies Cash In?
1/28/2015 11:49:00 AM - Seeking Alpha


What Investors Should Do About Imminent Obesity Drug Approvals In Europe
1/27/2015 8:38:00 AM - Seeking Alpha


Novo Nordisk - Curing The World One Dose At A Time
1/26/2015 2:16:00 PM - Seeking Alpha


A New Price Estimate Now That Afrezza Is Launching
1/26/2015 8:58:00 AM - Seeking Alpha


Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment
1/23/2015 12:32:00 PM - Seeking Alpha


European Stocks Poised For Higher Open
1/23/2015 2:20:00 AM - RTT News


ADXS In Focus, EGLT Soars, NEO Boosts Outlook, RMD Hits Record High
1/22/2015 10:28:00 PM - RTT News


Novo Nordisk Gets Positive CHMP Opinion For Obesity Drug Saxenda
1/22/2015 4:01:00 PM - RTT News


News Flash: The Endocrine Society Recommends Weight Loss Medications
1/21/2015 11:15:00 AM - Seeking Alpha


Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog
1/20/2015 2:10:00 PM - Investopedia


Dividend Contenders: 48 Increases Expected In The Next 11 Weeks
1/16/2015 6:39:00 PM - Seeking Alpha


Seeking Alpha's Biotech Weekly: 2014's Approval-Palooza, Ebola In Scotland, And More
1/2/2015 4:00:00 PM - Seeking Alpha


Eminence Capital raises position in CBS Outdoor Americas Inc.
12/30/2014 9:43:00 AM - Market Realist


Can High Priced Novo Nordisk Anti-Obesity Injection Make It?
12/29/2014 1:30:00 PM - Seeking Alpha


The Obesity Treatment Market Could Finally Achieve Some Of Its Potential In 2015
12/29/2014 1:24:00 PM - Seeking Alpha